University of Namibia   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Windhoek Namibia (1992)

Organization Overview

First Clinical Trial
2019
NCT04094727
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

University of Namibia

Active Ingredients

Drugs in Phase 4 Trials (2)

artemether (1 trial)

lumefantrine (Coartem) (1 trial)

Drugs in Phase 3 Trials (1)

atorvastatin (lipitor) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Inflammation (Phase 3)

Malaria (Phase 4)

Tuberculosis (Phase 3)

Tuberculosis, Pulmonary (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3